Mus vs Niue: Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC
Mus
93.0%
in 2025
Niue
99.0%
in 2025
Mus rank
1st
Niue rank
1st
Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC over time
- Mus
- Niue
How they compare
Niue currently reports 99.0% against 93.0% in Mus, a difference of 6.0%.
That makes Niue's figure about 1.1 times Mus's.
The two have swapped places 2 times across 26 shared years of data; in 2000 it was Niue ahead.
Mus ranks 1st and Niue ranks 1st of 2 regions.
Niue has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mus | Niue | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.1% | 93.9% | 44.8% | Niue |
| 2010s | 92.0% | 98.8% | 6.8% | Niue |
| 2020s | 94.5% | 99.0% | 4.5% | Niue |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Mus or Niue?
- Niue, at 99.0% against 93.0% in Mus as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Mus and Niue?
- 6.0%, with Niue ahead.
- How many years of comparable data are there for Mus and Niue?
- 26 years are reported by both, from 2000 to 2025.
- How do Mus and Niue rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Mus ranks 1st and Niue ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.